LISTEN
on air now
Advertisement
Advertisement
Advertisement

Memphasys: Now this is rare – a biotech that reaches commercialisation

Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device.

BULLS N' BEARS
Advertisement